Professor Christoph Rischpler, who is Professor of Nuclear Cardiology at the Medical Faculty of the University of Duisburg-Essen, in Germany, concentrated on the value PET/CT and PET/MR in cardiovascular imaging. He focused on PET/MRI in viability imaging and myocarditis, and PET/CT with a role in endocarditis and sarcoidosis “I think hybrid PET/CT and PET/MRI is very nice because you have synergistic use of the modalities,” said Professor Rischpler. “You get a detailed multimodal cardiac assessment and you can also use the form of molecular imaging using novel tracers – for example, fibroblast activation, innervation and neo-angiogenesis – and by that you get an integrated investigation of morphology, biology and function, which results in improved understanding of cardiac physiology and by that you improve your diagnosis and your therapy.”
Dr Teemu Maaniitty from the Department of Clinical Physiology, nuclear medicine and PET at Turku University Hospital, Finland, discussed software image fusion in the session.
Terrence Ruddy is Director of Nuclear Cardiology at the University of Ottawa Heart Institute and a Professor in the Division of Cardiology in the Department of Medicine and cross-appointed to the Division of Nuclear Medicine in the Department of Radiology. His research focuses on the development and validation of imaging techniques using SPECT and PET radiotracers for the diagnosis and evaluation of cardiovascular disease.
Christoph Rischpler is Professor of Nuclear Cardiology at the Medical Faculty of the University of Duisburg-Essen (UDE). The focus of his research is the visual representation of inflammatory processes, new blood vessels or nerve tracts that develop after a heart attack in procedures that combine positron emission (PET) and magnetic resonance tomography (MRT).
Source: Healthcare in Europe